N-acetylcysteine for prevention of radiocontrast induced nephrotoxicity: the importance of dose and route of administration.
Dose and route of administration of N-acetylcysteine are key factors to consider when evaluating whether this agent is effective in preventing radiocontrast induced nephropathy.
Shalansky
S J
SJ
Pate
G E
GE
Levin
A
A
Webb
J G
JG
D000111:Acetylcysteine / Q000008:administration & dosage*; D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007262:Infusions, Intravenous; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*
D003287:Contrast Media; D000111:Acetylcysteine